Incyte (INCY) Other Non Operating Income (2017 - 2026)
Incyte (INCY) posted Other Non Operating Income of $2.8 million for Q1 2026, down 51.02% on a QoQ basis from $5.7 million in Q4 2025, and down 65.74% year-over-year from $8.1 million in Q1 2025.
Incyte (INCY) Other Non Operating Income (2017 - 2026) Analysis & Trends
Incyte's Other Non Operating Income history runs 10 years deep, the most recent figure standing at $2.8 million for Q1 2026.
- Quarterly Other Non Operating Income fell 65.74% year-over-year to $2.8 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $19.8 million (down 13.71% YoY) and the FY2025 annual result came in at $25.1 million, up 96.03% from the prior year.
- Other Non Operating Income was $2.8 million for Q1 2026 at Incyte, down from $5.7 million in the prior quarter.
- Across five years, Other Non Operating Income topped out at $46.4 million in Q3 2023 and bottomed at -$108.0 million in Q4 2023.
- A 5-year average of $3.2 million and a median of $4.9 million in 2024 frame the typical range for Other Non Operating Income.
- Peak annual rise in Other Non Operating Income reached 8073.95% in 2023, while the deepest fall reached 681.66% in 2023.
- Incyte's Other Non Operating Income stood at -$13.8 million in 2022, then sank by 681.66% to -$108.0 million in 2023, then soared by 101.49% to $1.6 million in 2024, then soared by 251.15% to $5.7 million in 2025, then plunged by 51.02% to $2.8 million in 2026.
- Business Quant data shows INCY's Other Non Operating Income at $2.8 million in Q1 2026, $5.7 million in Q4 2025, and $4.0 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - |
| 10 | Incyte | 23.47 Bn | 19.46 Bn | 1.17 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 2.77 Mn |
| Dec 31, 2025 | 5.66 Mn |
| Sep 30, 2025 | 4.04 Mn |
| Jun 30, 2025 | 7.31 Mn |
| Mar 31, 2025 | 8.10 Mn |
| Dec 31, 2024 | 1.61 Mn |
| Sep 30, 2024 | 4.93 Mn |
| Jun 30, 2024 | 8.29 Mn |
| Mar 31, 2024 | -2.03 Mn |
| Dec 31, 2023 | -107.98 Mn |
| Sep 30, 2023 | 46.37 Mn |
| Jun 30, 2023 | 42.67 Mn |
| Mar 31, 2023 | 32.87 Mn |
| Dec 31, 2022 | -13.81 Mn |
| Sep 30, 2022 | 11.51 Mn |
| Jun 30, 2022 | 522,000.00 |
| Mar 31, 2022 | 1.26 Mn |
| Dec 31, 2021 | 5.72 Mn |
| Sep 30, 2021 | 1.95 Mn |
| Jun 30, 2021 | 4.39 Mn |